Podcasts / Shingles vaccination in the immunocompromised – Which option for which patient?
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
In this Healthed lecture, infectious diseases physician, Prof Tony Cunningham AO explains which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax). Prof Cunningham also describes how immunocompromised patients fit into one of three basic categories. Each of these categories warrants a different degree of caution, and each warrants a different approach to vaccination choice.
This educational activity was developed by Healthed at the request of and with funding from GSK.
Based on this educational activity, complete these learning modules to gain additional CPD.
Fracture Prevention and Osteoporosis Management After Menopause
Ophthalmology Update: New Treatments for Old Conditions
Testosterone for Men – Common Myths and Recent Development
Conversation Strategies for Unfunded Vaccinations
expert
Infectious Diseases Physician; Director, Centre for Virus Research at The Westmead Institute for Medical Research
Browse the latest podcasts from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.